I leave the critical thinking in biotech and the ability to run a biotech business to the experts... and that would be those who are either running or advising this company. Too many armchair CEOs and wanna-be biotech analysts here get some little topic in their brain and repeatedly try to sound intelligent, when in reality they don't know Jack about it.

Remember all the critical thinking that went in the endless rants over the low sensitivity numbers reported in July? Open mouth, insert a foot the size of Alaska. Then become an pseudo-expert on multivariate analysis and try to educate everyone else on the basics, hoping everyone will forget your prior rants and looking like a fool.

My intelligent, critical analysis of my Amarantus investment doesn't need explanation. The writing is on the wall for anyone to see who doesn't have there head up their own ass.